Skip Navigation



Human Molecular Genetics Advance Access published online on March 1, 2007
Human Molecular Genetics, doi:10.1093/hmg/ddm028
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
16/7/731    most recent
ddm028v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kranz, C.
Right arrow Articles by Freeze, H. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kranz, C.
Right arrow Articles by Freeze, H. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

COG8 deficiency causes new Congenital Disorder of Glycosylation type IIh

Christian Kranz1,¶, Bobby G. Ng1,¶, Liangwu Sun1, Vandana Sharma1, Erik A. Eklund1,, Yoshiaki Miura1,, Daniel Ungar2, Vladimir Lupashin3, Dennis R. Winkel4, John F. Cipollo5, Catherine E. Costello5, Eva Loh6, Wanjin Hong6 and Hudson H. Freeze1,*

1 Burnham Institute for Medical Research, La Jolla, California 92037, USA 2 Princeton University, Department of Molecular Biology, Princeton, New Jersey 08544, USA 3 University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA 4 Highland Park Professional Building, Kalispell, Montana 59901, USA 5 Boston University School of Medicine, Boston, Massachusetts 02118-2526, USA 6 Institute of Molecular & Cell Biology, 61 Biopolis Drive, Singapore 138671, Singapore

* Corresponding author Hudson H. Freeze, Glycobiology and Carbohydrate Chemistry Program, Burnham Institute for Medical Research, 10901 N. Torrey Pines Rd, La Jolla, CA 92037, phone: 858-646-3142, fax: 858-713-6281, E-mail: hudson{at}burnham.org

Received February 9, 2007; Revised February 12, 2007; Accepted February 12, 2007

We describe a new Type II congenital disorder of glycosylation (CDG-II) caused by mutations in the Conserved Oligomeric Golgi (COG) complex gene, COG8. The patient has severe psychomotor retardation, seizures, failure to thrive, and intolerance to wheat and dairy products. Analysis of serum transferrin and total serum N-glycans showed normal addition of one sialic acid, but severe deficiency in subsequent sialylation of mostly normal N-glycans. Patient fibroblasts were deficient in sialylation of both N- and O-glycans, and also showed slower brefeldin A (BFA) - induced disruption of the Golgi matrix, reminiscent of COG7-deficient cells. Patient fibroblasts completely lacked COG8 protein and had reduced levels and/or mislocalization of several other COG proteins. The patient had two COG8 mutations which severely truncated the protein and destabilized the COG complex. The first, IVS3 + 1G > A, altered the conserved splicing site of intron 3, and the second deleted two nucleotides (1687-1688 del TT) in exon 5, truncating the last 47 amino acids. Lentiviral-mediated complementation with normal COG8 corrected mislocalization of other COG proteins, normalized sialylation, and restored normal BFA-induced Golgi disruption. We propose to call this new disorder CDG-IIh or CDG-II/COG8.

Present address: Erik A. Eklund: Lund University, Department for Cell and Molecular Biology, BMC C13, 221 84 Lund, Sweden

Present address: Yoshiaki Miura: Hokkaido University, Sapporo, Japan

These authors contributed equally


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum Mol GenetHome page
P. Paesold-Burda, C. Maag, H. Troxler, F. Foulquier, P. Kleinert, S. Schnabel, M. Baumgartner, and T. Hennet
Deficiency in COG5 causes a moderate form of congenital disorders of glycosylation
Hum. Mol. Genet., November 15, 2009; 18(22): 4350 - 4356.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
E. Reynders, F. Foulquier, E. Leao Teles, D. Quelhas, W. Morelle, C. Rabouille, W. Annaert, and G. Matthijs
Golgi function and dysfunction in the first COG4-deficient CDG type II patient
Hum. Mol. Genet., September 1, 2009; 18(17): 3244 - 3256.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
B. C. Richardson, R. D. Smith, D. Ungar, A. Nakamura, P. D. Jeffrey, V. V. Lupashin, and F. M. Hughson
Structural basis for a human glycosylation disorder caused by mutation of the COG4 gene
PNAS, August 11, 2009; 106(32): 13329 - 13334.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
Y. Miura, M. Hato, Y. Shinohara, H. Kuramoto, J.-i. Furukawa, M. Kurogochi, H. Shimaoka, M. Tada, K. Nakanishi, M. Ozaki, et al.
BlotGlycoABCTM, an Integrated Glycoblotting Technique for Rapid and Large Scale Clinical Glycomics
Mol. Cell. Proteomics, February 1, 2008; 7(2): 370 - 377.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
C. Perez-Cerda, D. Quelhas, A. I. Vega, J. Ecay, L. Vilarinho, and M. Ugarte
Screening Using Serum Percentage of Carbohydrate-Deficient Transferrin for Congenital Disorders of Glycosylation in Children with Suspected Metabolic Disease
Clin. Chem., January 1, 2008; 54(1): 93 - 100.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.